EFFECT OF STEROIDS AND ANTISTEROIDS ON HUMAN MENINGIOMA CELLS IN PRIMARY CULTURE

被引:24
作者
BLANKENSTEIN, MA
VANDERMEULENDIJK, C
THIJSSEN, JHH
机构
关键词
D O I
10.1016/0022-4731(89)90119-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:419 / 421
页数:3
相关论文
共 9 条
[1]   ASSAY OF ESTROGEN AND PROGESTIN RECEPTORS IN HUMAN MENINGIOMA CYTOSOLS USING IMMUNOLOGICAL METHODS [J].
BLANKENSTEIN, MA ;
VANDERMEULENDIJK, C ;
THIJSSEN, JHH .
CLINICA CHIMICA ACTA, 1987, 165 (2-3) :189-195
[2]  
BLANKENSTEIN MA, 1987, HORMONAL MANIPULATIO, P61
[3]   HORMONE-TREATMENT OF MENINGIOMAS - LACK OF RESPONSE TO MEDROXYPROGESTERONE ACETATE (MPA) - A PILOT-STUDY OF 5 CASES [J].
JAASKELAINEN, J ;
LAASONEN, E ;
KARKKAINEN, J ;
HALTIA, M ;
TROUPP, H .
ACTA NEUROCHIRURGICA, 1986, 80 (1-2) :35-41
[4]   MODULATION OF MENINGIOMA CELL-GROWTH BY SEX STEROID-HORMONES INVITRO [J].
JAY, JR ;
MACLAUGHLIN, DT ;
RILEY, KR ;
MARTUZA, RL .
JOURNAL OF NEUROSURGERY, 1985, 62 (05) :757-762
[5]   HORMONOTHERAPY OF MENINGIOMAS WITH MEDROXYPROGESTERONE ACETATE - IMMUNOHISTOCHEMICAL DEMONSTRATION OF THE EFFECT OF MEDROXYPROGESTERONE ACETATE ON GROWTH FRACTIONS OF MENINGIOMA CELLS USING THE MONOCLONAL-ANTIBODY KI-67 [J].
MARKWALDER, TM ;
GERBER, HA ;
WAELTI, E ;
SCHAFFNER, T ;
MARKWALDER, RV .
SURGICAL NEUROLOGY, 1988, 30 (02) :97-101
[6]   LOCALIZATION OF PROGESTERONE-RECEPTOR WITH MONOCLONAL-ANTIBODIES TO THE HUMAN PROGESTIN RECEPTOR [J].
PRESS, MF ;
GREENE, GL .
ENDOCRINOLOGY, 1988, 122 (03) :1165-1175
[7]   PREGNANCY-RELATED PRIMARY BRAIN AND SPINAL TUMORS [J].
ROELVINK, NCA ;
KAMPHORST, W ;
VANALPHEN, HAM ;
RAO, BR .
ARCHIVES OF NEUROLOGY, 1987, 44 (02) :209-215
[8]   ENDOCRINE MANIPULATION OF MENINGIOMAS WITH MEDROXYPROGESTERONE ACETATE - EFFECT OF MPA ON GROWTH OF PRIMARY MENINGIOMA CELLS IN MONOLAYER TISSUE-CULTURE [J].
WAELTI, ER ;
MARKWALDER, TM .
SURGICAL NEUROLOGY, 1989, 31 (02) :96-100
[9]   BIOLOGICAL EXPRESSION OF STEROID-HORMONE RECEPTORS IN PRIMARY MENINGIOMA CELLS IN MONOLAYER-CULTURE [J].
ZAVA, DT ;
MARKWALDER, TM ;
MARKWALDER, RV .
CLINICAL NEUROPHARMACOLOGY, 1984, 7 (04) :382-388